Subscribe: Market Wire - Medical and Healthcare: Facilities and Providers
http://img.marketwire.com/rss/mwMHFP.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announces  cannabis  company  health  marketwired sep  marketwired september  marketwired  media  medical  new  sep  september 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Facilities and Providers

Marketwired - Hospitals, Facilities and Providers



Marketwired - Hospitals, Facilities and Providers



Last Build Date: Mon, 25 Sep 2017 12:31:29 EDT

Copyright: Copyright: (C) Marketwired
 



SANUWAVE Health to Host Conference Call to Provide Update on International Activity on Thursday, September 28, 2017

Mon, 25 Sep 2017 12:00:00 EDT

SUWANEE, GA--(Marketwired - Sep 25, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Thursday, September 28, 2017, beginning at 9:00AM Eastern Time, to provide a business update on international activity and answer questions.




Rennova Health's Labs Win Appeal in the Eleventh Circuit Court of Appeals in CIGNA Suit

Mon, 25 Sep 2017 09:20:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 25, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a leader in diagnostic and supportive software solutions for healthcare companies, announces that it received a favorable decision from the Eleventh Circuit Court of Appeals reversing an earlier decision by the U.S. District Court.




BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

Mon, 25 Sep 2017 09:00:00 EDT

FREDERICK, MD--(Marketwired - Sep 25, 2017) -  BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the protocol in May 2017, all 48 subjects needed to complete the study have been enrolled, as of September 20th, 2017.




Velano Vascular Adds Medical Device Industry Veterans to Leadership Team

Mon, 25 Sep 2017 08:05:00 EDT

Vascular access technology innovator positions for growth and deepening of product portfolio with addition of senior executives from Abbott and Teleflex Incorporated




ALRT Adding International Reference Dosing to Insulin Dose Adjustment (IDA) Feature for International Market Expansion

Mon, 25 Sep 2017 08:00:00 EDT

Product development underway to add reference doses based on International Diabetes Federation, Australia, Canada, New Zealand and UK Guidelines




Food Safety: How Representative Sampling Can Reduce Your Risk, New Webinar Hosted by Xtalks

Mon, 25 Sep 2017 07:30:00 EDT

Expanding regulations, foodborne illness outbreaks, and product recalls are intensifying demand for food safety. The challenges in food production are growing more intense every year. How can you keep up?




Claims Substantiation - An Integrated Clinical and Regulatory Approach, New Webinar Hosted by Xtalks

Mon, 25 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 25, 2017) - During a live broadcast on Wednesday, October 11, 2017, featured speakers from Nutrasource will discuss how:




"Made in Detroit," the Theme for the Stonecrest of Troy Grand Opening - Alzheimer Fund Raiser; WVSN REPORTS

Mon, 25 Sep 2017 06:00:00 EDT

TROY, MI--(Marketwired - September 25, 2017) - Stonecrest of Troy senior living held a huge grand opening celebration and fundraising event on Thursday, August 24 at their newest location in Troy, Michigan. The proceeds raised during the event were donated to benefit the Alzheimer Association. The theme of the event was, "Made in Detroit." The event drew over 600 visitors from the general public to view hundreds of classic cars on display, compliments of the Holly Car Club and the Tri Five Woodward Cruisers. Two professional Disc Jockeys spun 1950's rock n roll music to the delight of the crowd and dancers from the Arthur Murray Dance Studio of Sterling Heights, MI provided "dance steps" from 1950's dances. The dignitaries that cut the ribbon on the new facility spanned from the Mayor of Troy to leaders of businesses that donated over $4,500.00 for Alzheimer's research funds.




Dr. Kaveh Alizadeh Unveils a New Web Presence for His NYC-Based Plastic Surgery Practice

Fri, 22 Sep 2017 16:50:00 EDT

Potential and returning patients are invited to learn about the plastic surgery and nonsurgical options available at Cosmoplastic Surgery, as well as about Dr. Kaveh Alizadeh's global humanitarian work.




Rennova Health, Inc. Announces Reverse Stock Split

Fri, 22 Sep 2017 16:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 22, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) today announced that effective at 5:00 pm, Eastern Time, on October 5, 2017 (the "Effective Time"), the Company will effect a 1 for 15 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on The NASDAQ Capital Market on Friday October 6, 2017, on a post-split basis.




ORHub (ORHB) Announces COO Leave of Absence

Fri, 22 Sep 2017 16:15:00 EDT

NEWPORT BEACH, CA--(Marketwired - Sep 22, 2017) - ORHub, Inc. (OTC: ORHB), a medical software company focused on delivering case-based data analytics at the speed of surgery, today announced that its Chief Operating Officer, Cyrus P. Olsen, will be taking a leave of absence, effective as of September 19.




The Alliance for Regenerative Medicine Submits Letter to Congress Detailing Concerns with the Senate's American Health Care Act

Fri, 22 Sep 2017 13:06:48 EDT

WASHINGTON, DC--(Marketwired - Sep 22, 2017) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, today sent a letter to U.S. Sens. Graham (R-SC), Cassidy, MD (R-LA), Heller (R-NV) and Johnson (R-WI), detailing concerns regarding the American Health Care Act (H.R. 1628).




Amedica Releases First and Second Quarter 2017 Preliminary Unaudited Earnings Report and Business Update

Fri, 22 Sep 2017 09:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - Sep 22, 2017) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced its preliminary earnings report for the first and second quarters ended March 31, 2017 and June 30, 2017, respectively, and provided a business update related to its business strategy and certain recent developments.




Cocrystal Pharma to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York

Fri, 22 Sep 2017 08:15:00 EDT

ATLANTA, GA and BOTHELL, WA--(Marketwired - Sep 22, 2017) - Cocrystal Pharma, Inc. (OTCQB: COCP) today announced that Dr. Gary Wilcox and James Martin will be presenting a company overview at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 8:35am in the InterContinental New York Barclay Hotel.




Overcoming the Challenges of Conducting Clinical Studies in Rare Pediatric Populations

Fri, 22 Sep 2017 08:08:27 EDT

TORONTO, ON--(Marketwired - September 22, 2017) - In an upcoming webinar on Wednesday, October 11, 2017 at 11am EDT (4pm BST/UK) experts from PRA Health Sciences including Scott Schliebner, Vice President of Rare Disease - Scientific Affairs, and Mark Sorrentino, MD, Vice President of the Center for Pediatric Clinical Development, will highlight some of the key challenges associated with conducting research within rare pediatric populations that are few in number to begin with, are geographically dispersed and are often not located near a research center.




Beware the Hidden Costs of Conducting Clinical Trials: Understanding the Landmines and How to Avoid Them

Fri, 22 Sep 2017 08:04:06 EDT

TORONTO, ON--(Marketwired - September 22, 2017) - In a complimentary webinar taking place on Wednesday, October 11, 2017 at 11am EDT (4pm BST/UK) experts from Medpace will explore four areas that can dramatically affect the cost and timelines of your clinical program and offer insight into elimination and control of these hidden landmines.




Olive Fertility Centre Voted Best Fertility Clinic Vancouver for the Third Year in a Row

Thu, 21 Sep 2017 17:25:33 EDT

VANCOUVER, BC--(Marketwired - September 21, 2017) - Olive Fertility Centre is proud to announce that they have been voted Best Fertility Clinic in Vancouver in the Georgia Straight Best of Vancouver Awards 2017.




SANUWAVE Health to Attend Upcoming Symposium on Advanced Wound Care (SAWC)

Thu, 21 Sep 2017 16:00:00 EDT

SUWANEE, GA--(Marketwired - Sep 21, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned attendance at the Symposium on Advanced Wound Care/Fall (SAWC/Fall), October 20 - 22, 2017 in Las Vegas, NV. The semi-annual SAWC meeting is the premier interdisciplinary wound care program and the largest annual gathering of wound care clinicians in the United States. More than 2,000 physicians, podiatrists, nurses, therapists, researchers, and scientists are expected to attend the 2017 SAWC/Fall meeting.




Cancer Care Patients and Families Prioritize High-Quality Relationships and Communication

Thu, 21 Sep 2017 14:33:59 EDT

Study in the October issue of The Joint Commission Journal on Quality and Patient Safety




Marijuana Company of America Announces Update on Hemp Growing Trials in Canada

Thu, 21 Sep 2017 13:51:01 EDT

ESCONDIDO, CA--(Marketwired - Sep 21, 2017) - MARIJUANA COMPANY OF AMERICA ("MCOA" or the "Company") (OTC PINK: MCOA), in conjunction with its joint venture partner, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC PINK: GBHPF), is pleased to provide an update on the hemp cultivation trials conducted in New Brunswick, Canada.




Florida Hospital First to Receive Draeger's Babyleo IncuWarmer Beds, Advancing Prenatal Care in U.S.

Thu, 21 Sep 2017 13:15:11 EDT

Nationally recognized hospital receives innovative NICU technology, helping pre-term babies go home sooner




Medical Innovation Holdings, Inc. (MIHI) Announces Recruitment of Industry Veteran as COO

Thu, 21 Sep 2017 12:18:49 EDT

Enhances leadership team with the recruitment of a senior leader executive in the health and wellness industry




NCQA Releases 2017 Health Insurance Plan Ratings

Thu, 21 Sep 2017 12:02:35 EDT

See Top 10 States with Highest Rated Health Insurance Plans




STARS to strand CEOs on mountaintop for CEO Rescue in the Rockies fundraiser

Thu, 21 Sep 2017 10:00:00 EDT

Alberta-based CEOs hope to raise $400,000 for STARS in exchange for mountaintop rescue

Media Advisory & Photo Op




Eyetronic therapy: New milestone reached with 300 patients treated

Thu, 21 Sep 2017 10:00:00 EDT

Proven optic nerve stimulation can improve field of vision in patients with glaucoma and other optic neuropathies




American Cannabis Company, Inc. Signs Exclusive Distribution Agreement with Earth Alive

Thu, 21 Sep 2017 08:30:00 EDT

DENVER, CO--(Marketwired - Sep 21, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) ("ACC"), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has signed an exclusive distribution agreement with Earth Alive, a leading Canadian clean-tech company that develops and manufactures state-of-the-art microbial technology-based products. This agreement allows for the commercialization of Earth Alive's premiere cannabis microbial inoculant product, called Dr. Marijane. Dr. Marijane is a certified organic root probiotic that promotes increased vegetative growth, improves the bioavailability of fertilizer programs, and sustains healthy development and structuring of plant roots.




Pharma Competitive Intelligence: Delivering Actionable Insights for Decision Making, New Webinar Hosted by Xtalks

Thu, 21 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 21, 2017) - In a live webinar taking place on Tuesday, October 10, 2017 at 10am EDT (3pm BST/UK) industry experts Jamie Munro, Global Practice Leader of Portfolio and Licensing and Karthik Subramanian, Senior Product Strategy Manager, both from Clarivate Analytics, will provide insight into current Pharma CI, including trends and best practices.




Mayo Clinic Doctor Joins Advanced Medical Isotope Corporation's (ADMD) Medical Advisory Board

Thu, 21 Sep 2017 07:22:00 EDT

RICHLAND, WA--(Marketwired - Sep 21, 2017) - Advanced Medical Isotope Corporation (OTC PINK: ADMD), a late stage radiation oncology focused medical device company strengthened its Medical Advisory Board with the recent addition of Dr. Beau Toskich from Mayo Clinic, who has been informally working with the Company's advisory board for the last six months.




Electronic Informed Consent: 2017 Industry Survey Results from Clinical Sites, New Webinar Hosted by Xtalks

Thu, 21 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 21, 2017) - It's an exciting time for the life sciences industry, with technology driving greater levels of efficiency, effectiveness and patient engagement and satisfaction in clinical trials.




Fraser Institute News Release: Canada one of highest spenders among universal health-care countries, but ranks near bottom on number of doctors and wait times

Thu, 21 Sep 2017 05:00:00 EDT

VANCOUVER, BC--(Marketwired - September 21, 2017) - Despite spending more on health care than almost every other comparable country with universal health care, Canada ranks near the bottom in the number of physicians and acute care beds -- and suffers from the longest wait times, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.




September 30 'Funding Cliff' Threatens Closure of Community Health Centers Nationwide - Open Door Family Medical Centers Takes on Advocacy Role

Wed, 20 Sep 2017 16:42:27 EDT

As Many as 5,000 Open Door patients in Westchester County Could Lose Access to Healthcare




Canna Security America Rated a Top Ancillary Business by Cannabis Business Executive

Wed, 20 Sep 2017 13:31:12 EDT

DENVER, CO--(Marketwired - Sep 20, 2017) - Canna Security America (CSA) (OTCQB: CSAX), the leading comprehensive security solutions provider catering to businesses in the licensed cannabis industry, is honored to be named in Cannabis Business Executive's 2017 Top 150 Ancillary Businesses list, released early September. Listed as the #2 security solutions provider, CSA ranks #57 overall in the national directory of 150 cannabis industry ancillary companies.




SHIEC Elects 2017-2018 Board of Directors

Wed, 20 Sep 2017 10:20:51 EDT

Collaborative Expands Board with Addition of Three New Seats




SANUWAVE Announces Exhibition at Medica in Cooperation With State of Georgia; Visit us at Booth 16D10-8 in Hall 16

Wed, 20 Sep 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Sep 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit, in conjunction with Georgia Department of Economic Development, at MEDICA in Dusseldorf, Germany on 13 -16 November 2017. SANUWAVE cordially invites you to our section of booth 16D10-8 in Hall 16. MEDICA is the world's leading trade fair for the medical industry. SANUWAVE is using this occasion to further educate on our lead wound care product, dermaPACE® and our industry leader for the treatment of various orthopedic conditions, orthoPACE®.




CFN Media Exclusive Interview with United Cannabis: Developing Anti-Inflammatory Pharmaceuticals

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with United Cannabis Corp.'s (OTCQB: CNAB) Chief Science Officer Dr. Brent Reynolds, PhD. In the interview, Dr. Reynolds discusses the importance of clinical development and how the company's recent acquisition of Prana Therapeutics plays into its overall strategy.




True Leaf: Crowdfunding Legal Cannabis Products Across North America -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining True Leaf Medicine International Ltd. (CSE: MJ) (CNSX: MJ) (MJ.CN) (OTCQB: TRLFF) and its pending Regulation A+ public offering that is giving anyone the opportunity to invest in hemp and cannabis products that will be fully legal in both the U.S. and Canada. True Leaf's mission is to create safe, natural cannabis based products that enhance the quality of life for both people and pets. The company already has pet products in the market, and is in the final stages of Canadian approval to grow and sell legal cannabis.




ABcann Global Enters Its Growth Phase (Plus Exclusive Interview) -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with ABcann Global Corporation's (TSX VENTURE: ABCN) (OTCQB: ABCCF) Aaron Keay, former CEO and current member of the Board of Directors. In the interview, Mr. Keay discusses the company's transition to new CEO Barry Fishman, as well as the opportunities ahead for the company in both Canada and internationally.




Abattis Prepares for Growth in Extracts -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (ATT.CN) (CNSX: ATT) (OTCQB: ATTBF) and why its proprietary extraction technology represents an important breakthrough that shouldn't be ignored. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. These opportunities include those companies focused on higher value cannabis extracts.




Protext Pharma Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance

Wed, 20 Sep 2017 08:30:00 EDT

Company Provides Update on its Cannabis License Application




Melissa Asserts Better Data Equals a Great Customer Experience

Wed, 20 Sep 2017 08:00:00 EDT

Consumer Data Enhancements Personalize Online Shopping in Real-Time; Global Intelligence Solutions Demonstrated at Shop.org




HemCare Health Services Appoints Telecom Veteran Daniel G. Cullen as Chief Technology Officer

Wed, 20 Sep 2017 08:00:00 EDT

LAS VEGAS, NV--(Marketwired - Sep 20, 2017) - HemCare Health Services Inc. (OTC PINK: HCRE) is pleased to announce the appointment of Daniel G. Cullen as Chief Technology Officer. Mr. Cullen will be responsible for HemCare Health Services technology strategy and execution. In this capacity he will lead the company's engineering and software development team and spearhead the company's new technology initiatives in the application of Blockchain technology. Mr. Cullen will report directly to John Wilkes, CEO of Hemcare.




Strategy Design & Formulation Considerations for GLP Toxicology Studies, New Webinar Hosted by Xtalks

Wed, 20 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 20, 2017) - A lack of planning for a new compound's GLP toxicology study can severely trip up your IND. Upfront planning to design a successful toxicology study, identify problems and allow time for solutions can help avoid costly delays. Toxicology study design requires a customized strategy that is relevant to the intended clinical indication and route of administration and is acceptable to regulatory authorities. Formulation development plays an important role in assessing the in-vivo properties of a molecule during preclinical development, such as overcoming solubility issues and maximizing exposure.




Next Generation Data Mapping and Analytics Solutions Improve the Speed and Quality of Preparing Data Submissions for FDA, New Webinar Hosted by Xtalks

Wed, 20 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 20, 2017) - FDA now requires drug development firms pursuing approvals to submit all clinical data in CDISC standards such as the Study Data Tabulation Model (SDTM). To meet this requirement, many companies are using labor-intensive, manual and error-prone data extraction and mapping techniques.




Fraser Institute Media Advisory: How does Canada's health-care system compare to other universal systems around the world? New study coming Thursday, Sept. 21

Wed, 20 Sep 2017 07:00:00 EDT

VANCOUVER, BC--(Marketwired - September 20, 2017) - On Thursday, Sept. 21, the Fraser Institute will release a new study on health care.




Dr. Ellen Turner, Dermatologist in Dallas, TX, To Feature "Best of 2017" Treatments in Exclusive October Showcase

Tue, 19 Sep 2017 18:30:00 EDT

As part of her efforts to continually educate patients and provide them with the most effective treatment protocols that cosmetic dermatology has to offer, dermatologist Dr. Ellen Turner is hosting "Showcase Showdown" at her Dallas practice on Oct. 26, 2017




Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor

Tue, 19 Sep 2017 10:30:00 EDT

HICKSVILLE, NY--(Marketwired - Sep 19, 2017) - Canbiola, Inc. (OTC PINK: CANB) announced today that the company has added Dr. Fratellone to its Medical Advisory Board and engaged Dr. Fratellone as a distributor for Canbiola products. Dr. Fratellone is an attending physician at St. Luke's Hospital, Roosevelt Hospital, and Beth Israel Hospital, and current professor at University of Bridgeport College of Naturopathic Medicine. In addition, he bridges East Meets West at the Center of Excellence in Bridgeport CT with author Dr. Peter D'Adamo of Eat Right for Your Blood Type. Dr. Fratellone has appeared on multiple shows, and is considered an expert in his field as well a visionary. Dr. Fratellone stated, "As one of the few MDs in the US who is also a registered herbalist, I believe in traditional and time honored treatments, but also to look outside of the box; to that end CBD is certainly part of the future in my opinion with clear benefits to patients. I look forwarded to working with Canbiola, as well as educating the public on the vast benefits of CBD through blogs and speaking engagements."




FDA Grants ALRT Clearance for Insulin Dose Adjustment (IDA) Feature

Tue, 19 Sep 2017 10:02:29 EDT

IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs




Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix(TM) Delivery System -- CFN Media

Tue, 19 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) and its recent acquisition of the BiPhasixT Transdermal Drug Delivery technology for the delivery of cannabinoids.




Medovex Corporation Launches DenerveX System in Spain with Distributor Prim SA

Tue, 19 Sep 2017 08:30:00 EDT

Training and First Order Scheduled for Week of September 19th




Rennova Health Announces Big South Fork Medical Center Provided Services to Over 1,000 Patients in First Month of Operation

Tue, 19 Sep 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 19, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that Big South Fork Medical Center's Emergency Room has received 1,005 visits in its first month of operation and admitted 45 patients for overnight stays.




Cannabis Science "Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids" Full Publication Released Today In Frontiers In Oncology

Tue, 19 Sep 2017 08:18:05 EDT

IRVINE, CA--(Marketwired - Sep 19, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the full publication of initial research results on using nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids in the world-renowned cancer research journal, Frontiers in Oncology, released today.




Melissa Offers Active Data Quality Deployment Strategies at Microsoft Ignite

Tue, 19 Sep 2017 08:00:00 EDT

Defining the Data Quality Edge Drives Build vs Buy Decisions; Consultative Strategies and Tools Demonstrated




Pharmacology to Payer: One Quantitative Drug Development Framework to Rule Them All

Tue, 19 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - This webinar will discuss how "pharmacology to payer" (P2P) can be used as a quantitative framework that bridges the disciplines of pharmacology, epidemiology, and health economics to support meaningful dialogue between industry, regulators, and payers.




Biologics in Dermatology: Considerations for Patients and Clinical Trials, New Webinar Hosted by Xtalks

Tue, 19 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - In an upcoming presentation experts Darcee Duke Strube, Senior Vice President of Novella Clinical's Dermatology Division and Dr. James J Milbauer, Dermatologist, Medical Monitor and Advisor will discuss the evolution of biologics within the dermatology landscape, with an emphasis on clinical trial considerations for sponsors developing biologic agents.




MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

Tue, 19 Sep 2017 05:21:20 EDT

HONG KONG, CHINA--(Marketwired - Sep 19, 2017) - MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage has historically been a challenge. MetLife Hong Kong's inclusive action will make medical protection more accessible to this group of people.